Holly Ahern Speaks at Focus on Lyme 2017

Professor Holly Ahern, of State University of New York Adirondack, knows about Lyme disease from two different angles. One, as a microbiologist who has thoroughly examined the scientific literature pertaining to tick-borne diseases, and two, as the mother of a daughter with chronic Lyme disease. In this 2017 presentation, videotaped by www.lymediseas... at the Focus on Lyme conference in Arizona, she shares her expertise with wit and scientific data.

[@elleoops777]

Thank You Holly, what an excellent historical account, and counter point to a series of studies that have for decades caused untold morbidity in chronic Lyme disease patients. If only we could hold the experts accountable? Now to debunk the concept that persister Borrelia in small short-term mouse antibiotic treatment studies, proves that further treatment in humans with antibiotics is useless because the bacteria that persist in ,ice are harmless (presumably in humans). That is quite an extrapolation from mouse to man! They assume non-dividing bacteria are not pathogenic or toxic, (and we know that mice as reservoirs of Borrelia are more tolerant of the presence of Borrelia in their bodies than humans) yet many of the scientists that condemn antibiotic treatment beyond the IDSA guidelines, showed Borrelia proteins to be both toxic to human brain cells, and invokes a lymphokine response that opens the Blood Brain Barrier, and has antigenic mimicry against at least five human tissues including cardiolipin, . myelin basic protein, flagellin and more. But more over most of these studies are not done using wild strain Borrelia found in nature, but rather high-passage B-31 Lab Strain which is a less virulent species not found in any ticks any where in the world, yet it has become the world standard for the source of antigen for Lyme serology tests.. Now add in the "Species-Factor" we now have 12 or more species of Borrelia in the "Lyme Group" and we have new players like B. myamotoi a Tick-Borne-Relapsing-Fever that is found in the black-legged hard-shelled ticks. Anyone of these new players could yield different results in patients and mice than B-31 B burgdorferi studies. Also in the 1990s most of these treatment studies did not screen out Bartonella infections. The clinical picture of what we see in sick chronic Lyme patients is supporting the conclusion that these CDC and NIH studies have reached dubious conclusions. Thanks for making it so crystal clear and also thanks to Elizabeth Maloney and Delong, Phillips, Blossom and others for taking the time to analyze the poor statistical methods of the NIH and CDC who are supposed to be setting the highest standards of science and instead appear to purposely be corrupting good science. Thanks for challenging their work, their methods and their wrong conclusions! TG